Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 88,314 $ 64,615
Accounts receivable 2,675 5,006
Accounts receivable due from related parties 1,316 1,316
Prepaid expenses and other current assets 10,456 11,298
Total current assets 102,761 82,235
Property, plant and equipment, net 66,486 153,040
Deferred engineering costs 109,940 106,425
Non-current restricted cash 3,467 3,867
Other non-current assets 33,246 36,755
Total assets 315,900 382,322
Current liabilities:    
Accounts payable 29,136 21,048
Accounts payable due to related parties (Note 7) 2,300 0
Accrued and other liabilities 41,195 33,003
Borrowings 33,892 78,528
Total current liabilities 106,523 132,579
Borrowings 106,144 58,121
Other non-current liabilities 27,320 25,337
Total long-term liabilities 133,464 83,458
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and 6,123,782 shares outstanding, respectively 61 61
Common stock, $0.01 par value, 800,000,000 and 400,000,000 authorized, respectively: 284,292,876 and 242,207,522 shares outstanding, respectively 2,627 2,211
Additional paid-in capital 848,431 769,639
Accumulated deficit (775,206) (605,626)
Total stockholders’ equity 75,913 166,285
Total liabilities and stockholders’ equity $ 315,900 $ 382,322
Common stock, shares authorized (in shares) 800,000,000 400,000,000